Metastatic Kidney Cancer x Uromigos 2024 UPDATES (Part 2)
Two Onc Docs
00:00
Intro
This chapter explores metastatic renal cell carcinoma and the key risk stratification tools used in clinical practice, with a focus on the IMDC classification. The speakers discuss its relevance, effectiveness, and the evolving understanding of patient selection for therapies like immune-based doublets.
Transcript
Play full episode
